Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -153,723 | -57,060 | -84,413 | -384,164 | -61,121 |
| Depreciation Amortization | 68,335 | 16,992 | 42,825 | 392,439 | 39,596 |
| Income taxes - deferred | -12,661 | -4,282 | -24,320 | -105,061 | -16,185 |
| Accounts receivable | 227 | -1,029 | -129 | 735 | 628 |
| Other Working Capital | -2,225 | -4,275 | 3,147 | -467 | -14,631 |
| Other Operating Activity | 29,041 | -18,212 | 14,250 | 38,633 | -3,072 |
| Operating Cash Flow | $-71,006 | $-67,866 | $-48,640 | $-57,885 | $-54,785 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,916 | 118,566 | 35,086 | -82,551 | 9,645 |
| PPE Investments | -578 | -1,113 | -7,261 | -3,971 | -2,287 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 324 |
| Purchase Of Investment | N/A | -121,580 | N/A | -12,601 | N/A |
| Investing Cash Flow | $28,338 | $-4,127 | $27,825 | $-99,123 | $7,682 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,908 | 1,382 | 453 | 637 | 143,870 |
| Other Financing Activity | 18,549 | 54,264 | 48,869 | 12,001 | 0 |
| Financing Cash Flow | $37,457 | $55,646 | $49,322 | $12,638 | $143,870 |
| Exchange Rate Effect | 68 | -1,003 | 2,372 | 1,004 | -2,175 |
| Beginning Cash Position | 36,942 | 54,292 | 23,413 | 166,779 | 72,187 |
| End Cash Position | 31,799 | 36,942 | 54,292 | 23,413 | 166,779 |
| Net Cash Flow | $-5,143 | $-17,350 | $30,879 | $-143,366 | $94,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,006 | -67,866 | -48,640 | -57,885 | -54,785 |
| Capital Expenditure | -589 | -1,138 | -7,264 | -3,996 | -2,287 |
| Free Cash Flow | -71,595 | -69,004 | -55,904 | -61,881 | -57,072 |